Phase 1b Safety Study of Xevinapant, Weekly Cisplatin, and RT in Participants With Unresected LA SCCHN (HyperlynX)
EMD Serono
EMD Serono
Barbara Ann Karmanos Cancer Institute
The Netherlands Cancer Institute
University of Texas Southwestern Medical Center
Fox Chase Cancer Center
Masonic Cancer Center, University of Minnesota
University of Pittsburgh
Rutgers, The State University of New Jersey
Dana-Farber Cancer Institute